DAX19.849 -0,2%ESt504.858 +0,1%Top 10 Crypto14,68 -3,3%Dow43.297 +0,9%Nas20.031 +1,4%Bitcoin94.182 -0,8%Euro1,0406 +0,1%Öl73,65 +1,0%Gold2.614 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Tesla A1CX3T Lilium A3CYXP Palantir A2QA4J Novo Nordisk A3EU6F MicroStrategy 722713 Amazon 906866 Apple 865985 Volkswagen (VW) vz. 766403 Rheinmetall 703000 Bayer BAY001 Mercedes-Benz Group (ex Daimler) 710000 Microsoft 870747 Allianz 840400 BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Ruhiger Wochenauftakt: DAX letztlich im Minus -- VW: Einigung im Tarifkonflikt -- BMW: Unregelmäßigkeiten bei Autoexporten -- Mercedes-Benz, BVB, AstraZeneca im Fokus
Top News
Tesla-Aktie & Co.: Künstliche Intelligenz setzt auf Trump-Trades Tesla-Aktie & Co.: Künstliche Intelligenz setzt auf Trump-Trades
HelloFresh plant Rückkauf eigener Aktien im Millionenwert HelloFresh plant Rückkauf eigener Aktien im Millionenwert
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Eli Lilly Aktie

NeuKaufenVerkaufen
Eli Lilly Aktien-Sparplan
763,90 EUR +24,60 EUR +3,33 %
STU
793,21 USD +0,21 USD +0,03 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.726,36 Mrd. EUR

KGV100,48Div. Rendite0,78%

WKN858560

ISINUS5324571083

SymbolLLY

Eli Lilly Aktien News

DatumMeistgelesen
PR NewswireLilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion
EN, Eli LillyLilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion
BenzingaWhat's Going On With Eli Lilly And Company Shares Wednesday?
BenzingaWhat's Going On With Eli Lilly and Company Shares Friday
MotleyFoolAre Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
PR NewswireLilly's tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity
EN, Eli LillyLilly's tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity
ZacksHere is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
BenzingaThis Is What Whales Are Betting On Eli Lilly and Co
BenzingaUnpacking the Latest Options Trading Trends in Eli Lilly and Co
BenzingaAnalyzing Eli Lilly and Co In Comparison To Competitors In Pharmaceuticals Industry
BenzingaWhy Eli Lilly and Company Shares Are Moving Lower On Thursday
BenzingaHere's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years
EN, Eli LillyLilly Confirms Date and Conference Call for Second-Quarter 2024 Financial Results Announcement
PR NewswireLilly Confirms Date and Conference Call for Second-Quarter 2024 Financial Results Announcement
BenzingaElon Musk Agrees With Former Executive Who Thinks 'Everyone' Has 'Strong' Opinions On Tesla Unlike In The Case Of Eli Lilly And LVMH
BenzingaExpert Outlook: Eli Lilly and Co Through The Eyes Of 25 Analysts
MotleyFoolLook Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
MotleyFoolCan These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?
ZacksEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
BenzingaWhat's Going On With Eli Lilly And Company Shares Thursday?
MotleyFoolWhy Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
BenzingaEli Lilly and Co's Options: A Look at What the Big Money is Thinking
BenzingaIn-Depth Analysis: Eli Lilly and Co Versus Competitors In Pharmaceuticals Industry
BenzingaUnpacking the Latest Options Trading Trends in Eli Lilly and Co
ZacksEli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
PR NewswireLilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
EN, Eli LillyLilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
BenzingaHere's How Much $100 Invested In Eli Lilly and Co 15 Years Ago Would Be Worth Today
PR NewswireLilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease
EN, Eli LillyLilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease
BenzingaInsights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector
EN, Eli LillyLilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria
PR NewswireLilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria
BenzingaThis Is What Whales Are Betting On Eli Lilly and Co
EN, Eli LillyLilly Declares Third-Quarter 2024 Dividend
PR NewswireLilly Declares Third-Quarter 2024 Dividend
ZacksInvestors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
PR NewswireLilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution
EN, Eli LillyLilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.